ARCHIVES

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test

This article is from The Cancer Letter archive.

Vol. 40 No. 13 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Programs to Average Eight Percent Increase Over ’87 Under House Total, Bit Some Would Vary

August 14, 1987

Drug Development Gets Extra $500,000

November 18, 1977

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

RFPS, RFAs Available

September 23, 1994

New Health Bills Could Affect Cancer Program

February 9, 1979